ADAR1 Capital Management’s Inozyme Pharma INZY Stock Holding History

ADAR1 Capital Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-37,161	Closed	-$149K	–	239
2025 Q2	$149K	Sell	37,161 -50,638	-58%	-$125K	0.02%	162
2025 Q1	$79.9K	Buy	87,799 +11,500	+15%	+$15.9K	0.01%	171
2024 Q4	$211K	Buy	+76,299	New	+$290K	0.04%	155

ADAR1 Capital Management's INZY Position: Q3 2025 in Review

ADAR1 Capital Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 37,161 shares — an estimated $149K sold.

ADAR1 Capital Management first reported a position in INZY in Q4 2024 and held it in 3 quarters. The position peaked at $211K in Q4 2024. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

ADAR1 Capital Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
ADAR1 Capital Management sold 37,161 Inozyme Pharma shares in Q3 2025, an estimated $149K.
ADAR1 Capital Management first reported a position in Inozyme Pharma in Q4 2024 and held it in 3 quarters.
ADAR1 Capital Management's Inozyme Pharma position peaked at $211K in Q4 2024.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on ADAR1 Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.